← Back to Search

Distance Reiki for Multiple Myeloma

N/A
Recruiting
Led By Martha Lacy, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with Multiple Myeloma within 6 months of their Autologous Stem Cell Transplant
Age ≥ 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 5 weeks
Awards & highlights

Study Summary

This trial is testing whether Reiki therapy can improve quality of life and immunity compared to no additional Reiki intervention.

Who is the study for?
This trial is for adults over 18 with Multiple Myeloma who've had a stem cell transplant within the last 6 months. They must speak English and have access to a computer with internet and video conferencing capabilities. Those not returning to Mayo Clinic Rochester or showing disease relapse post-transplant cannot participate.Check my eligibility
What is being tested?
The study is testing if Distance Reiki therapy can improve quality of life and immunity in patients compared to those receiving Sham (fake) Reiki or no Reiki at all after their stem cell transplant.See study design
What are the potential side effects?
Since Reiki is a non-invasive therapy involving directing energy, it's generally considered safe without physical side effects. However, emotional responses or discomfort due to relaxation may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had a stem cell transplant for my multiple myeloma less than 6 months ago.
Select...
I am 18 years old or older.
Select...
I speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 5 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of Distance Reiki among multiple myeloma (MM) outpatients.
Change in patient-reported overall quality of life
Change in patient-reported quality of life
Secondary outcome measures
Assessment of T-cell receptor repertoire and T-cell clonal diversity
Phenotypic characterization of circulating immune cells

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Standard of CareActive Control1 Intervention
Subjects will not receive any Reiki treatment
Group II: Distance ReikiActive Control1 Intervention
Subjects will be scheduled for once a week session of distance Reiki for 4 weeks.
Group III: Sham ReikiPlacebo Group1 Intervention
Subjects will be scheduled for once a week session of Sham distance Reiki for 4 weeks.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,191 Previous Clinical Trials
3,758,481 Total Patients Enrolled
76 Trials studying Multiple Myeloma
9,681 Patients Enrolled for Multiple Myeloma
Martha Lacy, MDPrincipal InvestigatorMayo Clinic

Media Library

Distance Reiki Clinical Trial Eligibility Overview. Trial Name: NCT04783038 — N/A
Multiple Myeloma Research Study Groups: Standard of Care, Distance Reiki, Sham Reiki

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cap on the total number of participants in this trial?

"Affirmative. Supporting evidence on clinicaltrials.gov indicates that this medical research, posted initially on January 27th 2021, is actively seeking participants. Approximately 30 patients need to be enrolled from one centre of care."

Answered by AI

Is enrollment in this experiment still available?

"Affirmative. The clinicaltrials.gov website demonstrates that this medical study is still looking for participants, with the initial posting occurring on January 27th 2021 and the last update coming April 11th 2022. 30 individuals must be recruited from a single healthcare centre to complete testing procedures."

Answered by AI
~8 spots leftby Jul 2025